Anadys Pharmaceuticals Inc – Underwriting Agreements – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Underwriting Agreements Filter

from SC 13D/A ~1 page Agreement of Joint Filing

from 8-K 43 pages 13,888,889 Shares of Common Stock Par Value $0.001 2,083,333 Over-Allotment Shares Anadys Pharmaceuticals, Inc. Underwriting Agreement

from 8-K 44 pages 5,813,954 Stock Anadys Pharmaceuticals, Inc. Placement Agent Agreement

from 8-K 28 pages 8,358,000 Shares and Warrants to Purchase 2,925,300 Shares Anadys Pharmaceuticals, Inc. Common Stock Placement Agent Agreement

from 8-K ~20 pages 5,000,000 Anadys Pharmaceuticals, Inc. Common Stock Underwriting Agreement

from SC 13G/A 1 page Exhibit 1 the Shares of the Issuer's Common Stock Reported as Beneficially Owned by Hbm Bioventures AG in This Schedule 13g Is Beneficially Owned, Directly or Indirectly, Through the Following Entities, Each of Which Is a Wholly-Owned Subsidiary of Hbm Bioventures AG: 1). Hbm Bioventures (Cayman) Ltd. 2). International Bm Biomedicine Holdings Inc. -8

from S-1/A ~50 pages Underwriting agreement